CORCEPT THERAPEUTCS
CORCEPT THERAPEUTCS operates in Diversified Metals & Mining.
CORCEPT THERAPEUTCS (HTD) - Total Assets
Latest total assets as of September 2024: €784.26 Million EUR
Based on the latest financial reports, CORCEPT THERAPEUTCS (HTD) holds total assets worth €784.26 Million EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CORCEPT THERAPEUTCS - Total Assets Trend (2016–2023)
This chart illustrates how CORCEPT THERAPEUTCS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CORCEPT THERAPEUTCS - Asset Composition Analysis
Current Asset Composition (December 2023)
CORCEPT THERAPEUTCS's total assets of €784.26 Million consist of 73.8% current assets and 26.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 21.8% |
| Accounts Receivable | €41.12 Million | 6.6% |
| Inventory | €7.73 Million | 1.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how CORCEPT THERAPEUTCS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CORCEPT THERAPEUTCS's current assets represent 73.8% of total assets in 2023, a decrease from 95.5% in 2016.
- Cash Position: Cash and equivalents constituted 21.8% of total assets in 2023, down from 75.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 6.6% of total assets.
CORCEPT THERAPEUTCS Competitors by Total Assets
Key competitors of CORCEPT THERAPEUTCS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
CORCEPT THERAPEUTCS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - CORCEPT THERAPEUTCS generates 0.78x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, CORCEPT THERAPEUTCS generates $ 17.08 in net profit.
CORCEPT THERAPEUTCS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.70 | 3.54 | 7.91 |
| Quick Ratio | 3.64 | 3.48 | 7.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €340.76 Million | € 309.65 Million | € 268.52 Million |
CORCEPT THERAPEUTCS - Advanced Valuation Insights
This section examines the relationship between CORCEPT THERAPEUTCS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.5% |
| Total Assets | €621.52 Million |
| Market Capitalization | $635.54K USD |
Valuation Analysis
Below Book Valuation: The market values CORCEPT THERAPEUTCS's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: CORCEPT THERAPEUTCS's assets grew by 6.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CORCEPT THERAPEUTCS (2016–2023)
The table below shows the annual total assets of CORCEPT THERAPEUTCS from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €621.52 Million | +6.53% |
| 2022-12-31 | €583.43 Million | +37.68% |
| 2021-12-31 | €423.76 Million | -25.88% |
| 2020-12-31 | €571.73 Million | +38.66% |
| 2019-12-31 | €412.31 Million | +32.28% |
| 2018-12-31 | €311.69 Million | +41.33% |
| 2017-12-31 | €220.54 Million | +220.77% |
| 2016-12-31 | €68.75 Million | -- |